Sotorasib (generic name: Sotorasib) is a prescription drug targeting a specific gene mutation (KRAS G12C) in non-small cell lung cancer. Its price is ···【Read More】
Update: 2026-02-25Source: Haiou HealthViews: 202
The price of Sotorasib varies significantly depending on the region, purchase channel, and dosage. The specific price should be confirmed with the hos···【Read More】
Update: 2026-02-25Source: Haiou HealthViews: 193
Encorafenib is indicated for patients with BRAF-V600E or V600K mutation-positive unresectable or metastatic melanoma, as well as BRAF-V600E mutation-p···【Read More】
Update: 2026-02-25Source: Haiou HealthViews: 204
Encorafenib is a targeted therapy used for cancers with BRAF gene mutations. Information regarding its price, clinical efficacy, and preparation for m···【Read More】
Update: 2026-02-25Source: Haiou HealthViews: 203
Approval Details and BackgroundArray BioPharma Announces FDA Approval of Braftovi (encorafenib) in Combination with Mektovi (binimetinib) for Unresect···【Read More】
Update: 2026-02-25Source: Haiou HealthViews: 188
Approval Details and BackgroundApril 8, 2020 - Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved B···【Read More】
Update: 2026-02-25Source: Haiou HealthViews: 191
Approval Details and BackgroundNEW YORK--(BUSINESS WIRE) October 12, 2023 -- Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Admin···【Read More】
Update: 2026-02-25Source: Haiou HealthViews: 193
Approval Details and BackgroundNEW YORK--(BUSINESS WIRE) December 20, 2024 -- Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Admi···【Read More】
Update: 2026-02-25Source: Haiou HealthViews: 189
Study Publication and BackgroundFRIDAY, May 30, 2025 -- For patients with BRAF V600E-mutated metastatic colorectal cancer, progression-free and overal···【Read More】
Update: 2026-02-25Source: Haiou HealthViews: 198
Approval AnnouncementNEW YORK—(BUSINESS WIRE) February 24, 2026 — Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (···【Read More】
Update: 2026-02-25Source: Haiou HealthViews: 212
If an overdose is suspected, the medication should be stopped immediately, continuous medical observation should be performed on the patient, and appr···【Read More】
Update: 2026-02-25Source: Haiou HealthViews: 232
If you forget to take the medication on time, there is no need to make up for the missed dose. Continue to take the next dose at the original schedule···【Read More】
Update: 2026-02-25Source: Haiou HealthViews: 229
The half-life of the drug in the body (the time required for the drug concentration to decrease by half) ranges from 2.5 to 6.1 hours. However, there ···【Read More】
Update: 2026-02-25Source: Haiou HealthViews: 232
There is currently no authoritative research data that clearly specifies the exact time required for the drug to take effect.【Read More】
Update: 2026-02-25Source: Haiou HealthViews: 229
Axitinib is a targeted therapy for advanced renal cell carcinoma (RCC). Staying informed about the latest price trends, preparation steps, and contrai···【Read More】
Update: 2026-02-25Source: Haiou HealthViews: 208
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos